Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis.
Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis.
复制标题
DOI:
10.1111/cas.13789
复制
发表时间:
2018-11
期刊:
影响因子:
5.7
通讯作者:
Lin KY
中科院分区:
文献类型:
--
作者:
Fang CL;Lin CC;Chen HK;Hseu YC;Hung ST;Sun DP;Uen YH;Lin KY
Although gastric cancer (GC) is one of the most common cancers, knowledge of its development and carcinogenesis is limited. To date, expression of ubiquitin‐specific protease 3 (USP3) in all types of cancer, including GC, is still unknown. The present study explored the involvement of USP3 in the carcinogenesis and prognosis of GC. We measured USP3 expression in normal and GC tissues and cell lines. Correlations between USP3 protein level and clinicopathological parameters, as well as the significance of USP3 protein level for disease‐free survival were assessed. Small hairpin RNA technology and transfection were used to investigate the effect of USP3 manipulation on cell proliferation and spreading. Moreover, xenograft proliferation and metastasis were used to explore the influence of USP3 on tumor growth and metastasis in animals. An increase in USP3 expression was observed in GC cells and tissues. The overexpression of USP3 was significantly correlated with several clinicopathological parameters and poor disease‐free survival. Multivariate Cox regression analysis showed that the overexpression of USP3 was an independent prognostic biomarker. Silencing of USP3 suppressed GC cell proliferation and spreading in vitro as well as xenograft proliferation and metastasis in vivo; however, opposite results were obtained when USP3 was overexpressed. Further studies showed that USP3 influenced cell proliferation and spreading by regulating the cell cycle control‐ and epithelial‐mesenchymal transition‐related molecules. This study suggests that USP3 overexpression can be a useful biomarker for predicting the outcomes of GC patients and that USP3 targeting represents a potential modality for treating GC.
登录
查看更多内容
影响因子:
4.2
作者:
Sun DP;Fang CL;Chen HK;Wen KS;Hseu YC;Hung ST;Uen YH;Lin KY
通讯作者:
Lin KY
影响因子:
4
作者:
Nishimura S;Oki E;Ando K;Iimori M;Nakaji Y;Nakashima Y;Saeki H;Oda Y;Maehara Y
通讯作者:
Maehara Y
影响因子:
4.6
作者:
Wang Z;Yang J;Di J;Cui M;Xing J;Wu F;Wu W;Yang H;Zhang C;Yao Z;Zhang N;Jiang B;Su X
通讯作者:
Su X
影响因子:
--
作者:
Qu, Qing;Mao, Yan;Shen, Kunwei
通讯作者:
Shen, Kunwei
DOI:
10.1016/s0140-6736(09)60617-6
发表时间:
2009-08-08
期刊:
Lancet (London, England)
影响因子:
--
作者:
Hartgrink HH;Jansen EP;van Grieken NC;van de Velde CJ
通讯作者:
van de Velde CJ